05:14 PM EST - Ambrilia Biopharma Inc. : said that its fourth quarter net loss was $6.27 million or $0.15 per share, compared to net income of $12.81 million or $0.45 per share for the same quarter of last year. Revenues for the fourth quarter amounted to $243 thousand, compared to $19.33 million in the corresponding quarter in 2006. Ambrilia Biopharma Inc.
shares T.AMB are trading off 2 cents at $0.30.
